Yong-Liang Zhu, Ph.D. Founder, CEO

• Ph.D. from University of California Berkeley, Molecular biology/Bioinformatics
• Track-record in drug discovery: One of the inventors of FDA approved personalized medicine (Vemurafenib®, 2011) and many other drugs in clinical trials worldwide
• Experienced entrepreneur: Co-founded NeuPharma Inc, a computational drug design company. 3 novel drugs in clinical trials in Australia, US and China, two of which formed collaboration with big pharma
• 20+ year experience in biopharma industry: Various positions including Plexxikon Inc, Elan Pharmaceuticals PLC, Obtained 30+ PCT or US patents

Dr. Kuang, Ph.D, Chief Medical Officer

• B.S. in Clinical medicine, Chongqing Medical University; DMH. University of Montpellier, France
• Over 20 years of experience in new drug development, clinical strategy, and international registration
• Leadership in developing antibodies, ADCs, and small molecule drugs. Multiple core management positions of several biomedical technology companies, and co-corresponding author (The Lancet Hematology)

Dr. Zhan, Ph.D, Director of CMC

• Director of CMC, Ph.D. in Biology from Second Military Medical University, B.S. Xiangya Medical College in Pharmacy
• Rich experience in new drug pharmacy and dosage forms and clinical RCT research
• Managed large task organization including planning and on-the-spot command risk control

Prof. Liu, Ph.D, Vice President of Research

• Ph.D. from Jiangnan Univeristy. Post-doc from University of Georgia
• Dean of the School of Bioengineering of a University, National Excellent Youth
• Engaged in the design of model microorganism Bacillus subtilis chassis cells, gene circuit construction and dynamic metabolic engineering research, Efficient production of important functional compounds. and Corresponding author (Nature MedicineLancet Hematology)

Mr. Han, Vice president and BD/marketing director

• Licensed pharmacist. B.S in Pharmacy, Shandong University of Traditional Chinese Medicine
• CEO of Shandong Keda Pharmaceutical Industrial Park, CEO of Norton (Tai’an) Medical Technology Co., Ltd.
• Successful entrepreneur – built a company with 150+ pharmaceutical chain stores in three years
• Extensive experience in new drug promotion and clinical communication in top three hospitals